RainDance Technologies increases commercial activities in Europe with series of technology seminars

RainDance Technologies, Inc.:

“We are delighted to welcome at each seminar a faculty of distinguished scientists and clinicians who represent some of Europe's most preeminent institutions, and who will present their breakthrough data and experiences using RainDance's technology in their academic and clinical pursuits.”

What: RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for human health and disease research, today announced it is increasing its commercial activities in Europe beginning with a series of technology seminars during the week of 24 May 2010.

Seminar topic: "Targeted re-sequencing? See what you've been missing."

During each seminar, RainDance executives will be joined by scientists from leading European research institutions to discuss the benefits of microdroplet PCR-based technology for sequence enrichment and resequencing validation using next-generation DNA sequencing in a number of research areas including molecular profiling and medical genetics.

When/Where: London (Monday, 24 May; Wellcome Collection), Amsterdam (Tuesday, 25 May; De Bazel Conference Centre), Munich (Wednesday, 26 May; Munich Leukaemia Laboratory (MLL)), Berlin (Friday, 28 May; Hilton Hotel).

Who: Confirmed speakers include:

• London: Dr. Ioannis Ragoussis, Wellcome Trust Centre for Human Genetics and Dr. Abdou ElSharawy, Institute of Clinical Molecular Biology, University of Kiel, Germany
• Amsterdam: Dr. Peter Verhasselt, Johnson & Johnson, Dr. Kornelia Neveling, Department of Human Genetics, Radboud University Nijmegen Medical Centre and Dr. Abdou ElSharawy, University of Kiel
• Munich: Dr. Torsten Haferlach, Vera Grossmann and Dr. Alexander Kohlmann of the Munich Leukaemia Lab (MLL) and Dr. John Carpten, The Translational Genomics Research Institute (TGen), USA
• Berlin: Dr. Wei Chen, Max Delbrück Centre for Molecular Medicine and Dr. John Carpten, TGen

Roopom Banerjee, RainDance Technologies President and CEO, will speak at the seminars and is available for media interviews.

"Europe has a long history of scientific innovation and patient care, and continues to be an important center of excellence across a range of cutting-edge research areas, notably medical genetics and translational medicine," said Mr. Banerjee. "We are delighted to welcome at each seminar a faculty of distinguished scientists and clinicians who represent some of Europe's most preeminent institutions, and who will present their breakthrough data and experiences using RainDance's technology in their academic and clinical pursuits."

SOURCE RainDance Technologies, Inc.